Josh Pettit
About Josh Pettit
Josh Pettit serves as the National Sales Director at Psivida, a position he has held since 2018. He has extensive experience in the pharmaceutical and ophthalmology sectors, having previously worked in various management roles at Bausch + Lomb, Novartis, and Mallinckrodt Pharmaceuticals.
Current Role at Psivida
Josh Pettit serves as the National Sales Director at Psivida, a position he has held since 2018. In this role, he is responsible for overseeing the national sales strategy and execution, focusing on the company's product offerings in the ophthalmology sector. His leadership contributes to the growth and market presence of Psivida in the competitive pharmaceutical landscape.
Previous Experience at Mallinckrodt Pharmaceuticals
Before joining Psivida, Josh Pettit worked at Mallinckrodt Pharmaceuticals as the Head of Sales for Ophthalmology from 2015 to 2018. His role involved managing sales operations and strategies within the ophthalmology division, contributing to the company's objectives during his tenure in Chesterfield, Derbyshire, United Kingdom.
Career at Bausch + Lomb
Josh Pettit spent six years at Bausch + Lomb from 2009 to 2015, where he held various management roles. His experience at this well-known company in the eye care industry equipped him with valuable insights and skills relevant to sales and management in the pharmaceutical sector.
Experience at Novartis
Prior to his time at Bausch + Lomb, Josh Pettit worked at Novartis as a Senior Key Account Specialist in Retina from 2005 to 2009. This role involved managing key accounts and building relationships within the retina segment, enhancing his expertise in the ophthalmic field.
Educational Background
Josh Pettit holds a Bachelor's degree from Baylor University, which he completed from 1996 to 2000. He furthered his education by obtaining a Master's degree from the University of London, studying from 2001 to 2003. His academic background has provided a foundation for his career in the pharmaceutical and sales industries.